Skip to Content Facebook Feature Image

Intrepid HK based swimmers swam around HK island to raise funds for oyster reef restoration

Business

Intrepid HK based swimmers swam around HK island to raise funds for oyster reef restoration
Business

Business

Intrepid HK based swimmers swam around HK island to raise funds for oyster reef restoration

2024-11-12 23:58 Last Updated At:11-13 00:15

The swim, fully supported by Wheelock Properties, successfully raises funds for The Nature Conservancy's (TNC) oyster reef restoration program, contributing to the improvement of water quality in Hong Kong.

HONG KONG, Nov. 12, 2024 /PRNewswire/ -- The "Happy Oysters Healthier Waters 80km Marathon Swim Challenge" was held, raising funds for The Nature Conservancy's (TNC) oyster reef restoration program in Hong Kong. In a remarkable feat of endurance and commitment, Day 1 of the relay swim and solo prone paddle has been completed. Day 2 relay swim is postponed to November 24th due to T3 typhoon warning, while the solo prone paddle started after the transition to T1 warning and has been completed.

A team of seven diverse swimmers undertook the challenge and completed Day 1 around Hong Kong Island on November 9th, swimming for 10 hours and 15 minutes under T1 typhoon conditions. Among them were Andres Tung, Carmelo Ficarra, Dario Pong, Donal O'Neil, Jonathan Lo, Ryan Leung, and Thomas Launay, each contributing their strength and determination to the cause. The original relay swim was planned for two days, swimming 45km around Hong Kong Island on November 9th, and covering an additional 35km from Hoi Ha Wan to Clear Water Bay on November 10th.

Despite the Day 2 swim relay was postponed, Douglas Woo completed the solo prone paddle as planned. Combined with yesterday's efforts, he completed the 80 km challenge over two days while prone paddling these two routes for the first time.

The event, initiated by the swimmers and fully supported by Wheelock Properties, is further bolstered by the complete backing of TNC's team. TNC has been involved from the very beginning, contributing to planning, on-site support, and promotion efforts. Together, the collaborative achievement exemplifies a dedication to positive environmental impact and biodiversity preservation, echoing Wheelock Properties' ESG principles in making positive impact on the environment. The swimmers' dedication, alongside generous public donations, are directed to TNC's oyster reef restoration program, which is critical for improving water quality and reversing the loss of oyster reefs in Hong Kong.

Bringing Back Oyster Reefs for Healthier Water

Oysters are vital ecosystem engineers that significantly enhance local water quality. A single oyster can filter 200 liters of water a day, transforming murky waters into healthier marine environments. Despite their crucial role, oyster reefs have historically been neglected and are now the most endangered marine habitat globally, with an estimated 85% lost due to overharvesting, coastal development, and pollution.

TNC leads the charge to restore Hong Kong's oyster reefs. With over 20 years of global expertise in shellfish restoration, TNC employs rigorous science and strategic partnerships to revive these vital ecosystems. By implementing innovative solutions and site demonstrations, TNC aims to restore Hong Kong's reefs at scale, bringing healthier water and enhancing biodiversity. The funds raised from the 80km Marathon Swim Challenge will specifically support restoration efforts in Lantau, contributing to TNC's goal of protecting 30% of the planet's oceans by 2030.

"Preserving the ocean presents a continuous journey. This swim reflects that very challenge — marked by determination, intensity, and a thrilling push beyond our limits. It also stands as a testament to our collective efforts, intended to encourage everyone to take a step forward in protecting our ocean," the swimmers jointly expressed.  

"We're deeply inspired by the dedication and resilience of the eight swimmers supporting our oyster reef restoration efforts," said Lulu Zhou, Director of Strategic Partnerships (Asia Pacific) and Hong Kong Program Lead of TNC. "Their incredible journey not only raises vital funds but also highlights the importance of restoring our marine ecosystems. Together, we're making a tangible difference for Hong Kong's waters. Thank you to the swimmers, Wheelock, and all supporters for your commitment to healthier water and biodiversity."

As we continue our fundraising efforts, we warmly invite everyone to participate in the Swim Challenge. Your generous support will directly benefit TNC's oyster reef restoration initiatives, improve water quality in Hong Kong, and help achieve the global goal of protecting 30% of the planet's oceans by 2030. Together, we can forge a brighter and more sustainable future for our oceans!

Donation details: 

FPS ID: 102517950
Account name: The Nature Conservancy Hong Kong Foundation Limited
*Please input the donation code "#80kmswim" at the message column.

For media photos, please download from the LINK

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Intrepid HK based swimmers swam around HK island to raise funds for oyster reef restoration

Intrepid HK based swimmers swam around HK island to raise funds for oyster reef restoration

PISCATAWAY, N.J., Nov. 13, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading scientists, industry experts, investors, and regulatory authorities at the GenScript Biotech Global Forum. This series of conferences aims to address key industrial trends in cell therapy and gene therapy.

For more information, please visit the forum website.
Scan QR code or click the link to register: https://bit.ly/477v0pa
(Register using code GSOM to reserve your free pass.)
 

In this November 20, GenScript Biotech Global Forum will take place in London during the Jefferies London Healthcare Conference. This year's forum will explore the theme "Unlock the Full Potential of Cell and Gene Therapies." This event aims to foster collaboration among industry leaders while tackling the challenges and opportunities in the CGT landscape.

Highlights of the Agenda Include

Navigating Challenges: Insights into the Future of CGT and Multiple Cell Therapy Technologies in Development

In recent years, cell and gene therapy has become a key player in biopharmaceuticals, with a growing number of approvals annually. CAR-T therapies are the most advanced, while innovations have led to a wider range of cell therapies, including CAR-NK, CAR-M, and TIL, addressing various challenging diseases.

However, the diverse landscape of new therapies and technologies presents numerous challenges. The forum will feature keynote speeches from prominent figures in cell and gene therapy, including Dr. James M. Wilson, President and CEO of Gemma Biotherapeutics; Dr. Miguel Forte, President of the International Society for Cell & Gene Therapy (ISCT) and CEO of Kiji Therapeutics, and Tom Whitehead, co-founder of the Emily Whitehead Foundation will also give a speech to share the life-saving stories of CAR-T therapy.

In-Depth Discussion on Gene Therapy, mRNA Vaccines and the CMC Challenges in Developing and Manufacturing CGT Product

The development of gene therapy and mRNA vaccine technologies has been transformative, particularly during the COVID-19 pandemic, and holds immense promise for treating rare diseases and genetic disorders. As advancements in gene editing reshape clinical applications, emerging innovations in gene therapy and mRNA vaccines are poised to revolutionize medicine. However, the transition of these technologies from research and development to clinical application brings significant challenges. Throughout the development and production of cell and gene therapies, issues related to CMC are prevalent. The quality of raw materials and the stability of supply chains directly impact early development, while the complexity and consistency of manufacturing processes, from small-scale trials to large-scale commercialization, remain key obstacles. Further optimization is needed in process scaling and standardization, alongside the ongoing challenge of ensuring product quality and safety in compliance with stringent regulatory standards for successful market entry. The forum will explore these challenges, as well as emerging market trends and future opportunities for innovation, through in-depth panel discussions.

Exploring the Investment Potential of CGT: A Future Outlook

The cell and gene therapy (CGT) industry faces challenges in investment returns due to high development costs, regulatory hurdles, and manufacturing complexities. However, significant opportunities exist in gene editing and cell-based therapies, which offer promise for treating various diseases. Attracting funding requires understanding the potential impact of these therapies and their path to commercialization. This forum will feature a fireside chat with investment insights, helping attendees explore CGT's potential and how to secure long-term returns as therapies progress toward commercialization.

For more information, please visit the forum website.
Scan QR code or click the link to register: https://bit.ly/477v0pa
(Register using code GSOM to reserve your free pass.)
 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.

Recommended Articles